ETS DE Francois International Ltd Pharmaceutical Import Profile — Benin (DGFT 2022–2026)

Name: ETS DE Francois International Ltd Pharmaceutical Import Records from India — 2 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

ETS DE Francois International Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $1.1M Trade | TransData Nexus

ETS DE Francois International Ltd

Pharmaceutical Importer · Benin · Analgesics & Antipyretics Focus · $1.1M Total Trade · DGFT Verified

ETS DE Francois International Ltd is a pharmaceutical importer based in Benin with a total trade value of $1.1M across 2 products in 2 therapeutic categories. Based on 36 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. ETS DE Francois International Ltd sources from 4 verified Indian suppliers, with Truestar Enterprise Private Limited accounting for 92.4% of imports.

ETS DE Francois International Ltd — Import Portfolio & Supplier Network

ETS DE Francois International Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to ETS DE Francois International Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Truestar Enterprise Private Limited	$3.5M	107	92.4%
Map Overseas	$133.6K	3	3.6%
Mangal Murti Enterprises	$100.0K

What Formulations Does ETS DE Francois International Ltd Import?

Formulation	Value	Ships
Pharmaceutical product barcadin syrup	$264.1K	9
Pharmaceutical product csc syrup	$226.2K	5
Pharmaceutical product super royal	$213.1K	5
Pharmaceutical product tapentadol	$190.7K	4
Pharmaceutical products csc syrup	$180.9K	4
Pharmaceutical products csmix syrup	$177.0K	4
Pharmaceutical product csmix syrup	$157.5K	4
Pharmaceutical products tamol-x225	$155.5K	5
Pharmaceutical products super royal	$154.5K	5
Pharmaceutical product csmix syrup	$146.5K	3
Pharmaceutical products super royal 225tabs tapentadol hydrochloride 125 MG carisoprodol BP 100 MG	$145.1K	3
Pharmaceutical product tamol-x225	$100.0K	2
Pharmaceutical product tafrodol x-225	$100.0K	2
Pharmaceutical product dsp syrup	$100.0K	2
Pharmaceutical products csmix syrup mfg veritas diphenhydramine hydrochloride b p 13 5 MG codeine phosphate	$93.0K	2

ETS DE Francois International Ltd imports 51 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Codeine	Analgesics & Antipyretics	$534.2K	18	0.5%	11
2	Diphenhydramine	Antihistamines & Allergy	$534.2K	18	1.7%	10

ETS DE Francois International Ltd imports 2 pharmaceutical products across 2 categories into Benin totaling $1.1M.

ETS DE Francois International Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

ETS DE Francois International Ltd is a pharmaceutical importer based in Cotonou, Benin. The company specializes in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily sourced from India. With a total import value of $1.1 million USD over 36 shipments from 2022 to 2026, ETS DE Francois International Ltd plays a significant role in supplying essential medications within the Beninese market. The company's product portfolio is concentrated in two therapeutic categories: Analgesics & Antipyretics and Antihistamines & Allergy, each accounting for 50% of their imports. Notably, their top two imported products, Codeine and Diphenhydramine, each valued at $534,000 USD, represent 100% of their import volume, indicating a highly concentrated sourcing strategy.

2Distribution Network

While specific details regarding ETS DE Francois International Ltd's warehouse locations and logistics capabilities are not publicly available, the company's consistent import activity suggests a well-established distribution network within Benin. The primary port of entry for their imports is Cotonou, the economic hub of Benin, facilitating efficient distribution across the country. Given the concentration of their imports in two specific product categories, it is likely that their distribution network is tailored to meet the demand for these therapeutic areas, ensuring timely and widespread availability of these medications throughout Benin.

3Industry Role

ETS DE Francois International Ltd functions as a primary wholesaler in Benin's pharmaceutical supply chain. By importing finished pharmaceutical formulations from India, they bridge the gap between international manufacturers and the local market, ensuring the availability of essential medications. Their focus on specific therapeutic categories indicates a strategic approach to meet the prevalent health needs within the country. The company's role is crucial in maintaining a steady supply of critical drugs, thereby supporting the overall healthcare infrastructure in Benin.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — ETS DE Francois International Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The sourcing strategy of ETS DE Francois International Ltd exhibits a high degree of concentration, with their top two imported products—Codeine and Diphenhydramine—each valued at $534,000 USD, accounting for 100% of their import volume. This indicates a reliance on a narrow product range, which could pose risks such as supply chain disruptions or market fluctuations affecting these specific products. However, the consistent import activity from a limited number of suppliers suggests a stable and established relationship, potentially mitigating some of these risks. The company's focus on these products may also reflect a strategic choice to dominate specific market segments, aligning with the prevalent health needs in Benin.

2Supply Chain Resilience

ETS DE Francois International Ltd's supply chain resilience appears robust, given their consistent import activity and established relationships with suppliers. The company's focus on a limited number of products and suppliers suggests a streamlined supply chain, which can enhance efficiency and reduce operational complexities. However, the lack of publicly available information on backup suppliers and shipping routes indicates potential vulnerabilities. To further strengthen their supply chain resilience, it would be prudent for the company to diversify its supplier base and establish contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into Benin — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Benin

1Regulatory Authority & Framework

The Agence Béninoise de Régulation et d'Enregistrement des Produits (ABREP) is the primary regulatory body overseeing the registration and regulation of pharmaceutical products in Benin. ABREP ensures that all pharmaceutical drugs manufactured, imported, exported, advertised, sold, distributed, or used in Benin are registered in accordance with the provisions of ABREP-2020 and related legislation. The registration process involves submitting necessary documentation through an ABREP-accredited legal agent, who guides applicants on the required documents for product registration. This regulatory framework aims to protect public health by ensuring the safety, efficacy, and quality of pharmaceutical products available in the country.

2Import Licensing & GMP

Import licensing requirements in Benin stipulate that all pharmaceutical products must be registered with ABREP before they can be imported, sold, or distributed. This process ensures that imported drugs meet the necessary safety and quality standards. Regarding Good Manufacturing Practice (GMP) certification, Benin recognizes certifications from reputable international bodies such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers like ETS DE Francois International Ltd are required to ensure that their suppliers hold valid GMP certifications from these recognized organizations to guarantee the quality of the pharmaceutical products they import.

ETS DE Francois International Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

ETS DE Francois International Ltd's focus on importing analgesics and antihistamines, particularly Codeine and Diphenhydramine, aligns with the prevalent health needs in Benin. These therapeutic areas address common conditions such as pain, fever, and allergic reactions, which are widespread in the population. The company's strategic emphasis on these products suggests a deep understanding of the local market demand and a commitment to providing essential medications that improve public health outcomes.

2Sourcing Profile

ETS DE Francois International Ltd's sourcing strategy is centered on importing generic pharmaceutical formulations from India, focusing on specific products within the analgesics and antihistamines categories. This approach allows the company to offer cost-effective medications while maintaining a high level of quality, as Indian manufacturers often adhere to recognized international standards. By concentrating on a limited number of products and suppliers, the company can streamline its procurement processes and establish strong relationships with key suppliers, ensuring a reliable supply chain for its imported products.

3Market Positioning

Seller's Guide — How to Become a Supplier to ETS DE Francois International Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with ETS DE Francois International Ltd, particularly by offering products that complement their existing portfolio in the analgesics and antihistamines categories. By providing high-quality, cost-effective generic formulations that meet international standards, new suppliers can position themselves as valuable partners. Additionally, diversifying the product range to include other therapeutic areas that align with the health needs in Benin could further strengthen the partnership and expand market reach.

2Requirements & Qualifications

Indian exporters seeking to supply ETS DE Francois International Ltd and the broader Benin market must ensure that their pharmaceutical products are registered with ABREP, the regulatory authority in Benin. This registration process requires compliance with local regulations and the submission of necessary documentation through an ABREP-accredited legal agent. Additionally, products must meet recognized international quality standards, such as EU GMP, WHO GMP, or PIC/S certifications, to be considered for importation into Benin.

3How to Approach

Frequently Asked Questions — ETS DE Francois International Ltd

What products does ETS DE Francois International Ltd import from India?

ETS DE Francois International Ltd imports 2 pharmaceutical products across 2 categories. Top imports: Codeine ($534.2K), Diphenhydramine ($534.2K).

Who supplies pharmaceuticals to ETS DE Francois International Ltd from India?

ETS DE Francois International Ltd sources from 4 verified Indian suppliers. The primary supplier is Truestar Enterprise Private Limited (92.4% of imports, $3.5M).

What is ETS DE Francois International Ltd's total pharmaceutical import value?

ETS DE Francois International Ltd's total pharmaceutical import value from India is $1.1M, based on 36 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does ETS DE Francois International Ltd focus on?

ETS DE Francois International Ltd imports across 2 categories. The largest: Analgesics & Antipyretics (50.0%), Antihistamines & Allergy (50.0%).

Get Full ETS DE Francois International Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.